DR. M. CLAUS
ActiveSummary
DR. M. CLAUS has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €696k and a net result of €55k. Equity is growing by ~9.7% per year across the filed fiscal years. Its solvency ranks better than 41% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
82
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability75▲+1
Solvency83▲+2
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55k at 30 days acceptable
Liquidity ample (current ratio 4.89 against 4.08 in 2023; short-term debt: 8.2% and cash: 7.1% of total assets), and 41.8% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-06-2025, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
31 d early
2023
20 d early
2022
28 d early
2021
25 d early
2020
17 d early
2019
31 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€696k▲ 8.6%
2023 · €641k
2018: €343k
2019: €442k
2020: €551k
2021: €628k
2022: €589k
2023: €641k
2018 → 2024
Total assets
€1.20M▲ 4.4%
2023 · €1.15M
2018: €1.15M
2019: €1.15M
2020: €1.21M
2021: €1.23M
2022: €1.17M
2023: €1.15M
2018 → 2024
Net result
€55k▲ 7.1%
2023 · €52k
2018: €97k
2019: €99k
2020: €109k
2021: €78k
2022: €45k
2023: €52k
2018 → 2024
Working capital
€380k▲ 21.0%
2023 · €314k
2018: €121k
2019: €194k
2020: €298k
2021: €347k
2022: €271k
2023: €314k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€551k-€628k▲ 14.1%€589k▼ 6.2%€641k▲ 8.8%€696k▲ 8.6%
Operating result€155k-€110k▼ 28.9%€72k▼ 34.9%€78k▲ 9.3%€82k▲ 5.2%
Net result€109k-€78k▼ 28.8%€45k▼ 41.5%€52k▲ 14.0%€55k▲ 7.1%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 5% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.20M
Fixed assets
€718k ▼ 1.6%
Current assets
€478k ▲ 14.8%
Equity and liabilities €1.20M
Equity
€696k ▲ 8.6%
Debt
€500k ▼ 1.0%
Debt's share of the balance-sheet total falls from 44.1% to 41.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€104k▲
2023 · €99k
Cash flow
€77k▲
2023 · €72k
Current ratio
4.89▲
2023 · 4.08
Debt to equity
0.72▼
2023 · 0.79
ROE
7.9%▼
2023 · 8.1%
ROA
4.6%▲
2023 · 4.5%
Interest coverage
11.16▲
2023 · 9.73
Debt ≤ 1 year
€98k▼
2023 · €102k
Debt > 1 year
€332k▼
2023 · €383k
Income taxes
€21k▲
2023 · €20k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 45 lines
Balance sheet
Code20232024
Assets
Total assets20/58€1.15M€1.20M▲
Fixed assets21/28€730k€718k▼
Tangible fixed assets22/27€730k€718k▼
Land and buildings22€728k€708k▼
Plant, machinery and equipment23-€2k
Furniture and vehicles24€1k€8k▲
Current assets29/58€416k€478k▲
Amounts receivable within one year40/41€6k€6k▲
Other amounts receivable41€6k€6k▲
Current investments50/53€315k€383k▲
Cash at bank and in hand54/58€40k€85k▲
Deferred charges and accrued income490/1€56k€4k▼
Equity and liabilities
Total equity and liabilities10/49€1.15M€1.20M▲
Equity10/15€641k€696k▲
Contributions10/11€12k€12k=
Reserves13€628k€683k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€626k€682k▲
Amounts payable17/49€505k€500k▼
Amounts payable after more than one year17€383k€332k▼
Financial debts170/4€383k€332k▼
Amounts payable within one year42/48€102k€98k▼
Current portion of amounts payable after more than one year42€50k€51k▲
Trade debts44€168-
Suppliers440/4€168-
Other amounts payable47/48€52k€46k▼
Accrued charges and deferred income492/3€21k€71k▲
Income statement
Code20232024
Non-recurring operating income76A€35k-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€21k€22k▲
Other operating charges640/8€6k€6k▲
Gross operating margin9900€105k€110k▲
Operating profit (loss)9901€78k€82k▲
Financial income75/76B€3k€3k▲
Recurring financial income75€3k€3k▲
Financial charges65/66B€10k€9k▼
Recurring financial charges65€10k€9k▼
Profit (loss) for the period before taxes9903€71k€76k▲
Income taxes67/77€20k€21k▲
Profit (loss) for the period9904€52k€55k▲
Profit (loss) for the period to be appropriated9905€52k€55k▲
Appropriation of the result
Profit (loss) to be appropriated9906€52k€55k▲
Transfer to equity691/2€52k€55k▲
To the legal reserve6920€52k-
To other reserves6921-€55k
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
11-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
03-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet €45k ▼41.5%
Net result drops to €45k, the lowest in the series; recovery starts the following year.
06-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
14-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Highest result since 2018net €109k ▲9.9%
Net result €109k, the highest in the series.
31-12
Financial
Equity above €500kEq €551k ▲24.6%
3 profitable years in a row build equity to €551k.
30-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
25-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
11-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
26-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
20-07
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zoersel · 1 establishment unit since 2005
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Olmenlei 712980 ZoerselGround area
1,197 m²
Building footprint
204 m²
Parcel 11055A0062/00P007, Flanders. Linked by address, not a title deed.
1 establishment unit
DR. M. CLAUS
since 20052.249.828.985
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11055A0062/00P007 | Flanders | 1,197 m² | 1 · 204 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Marc Claessens
BE 0832.634.142
Schilde · Eq €695,896
DOKTER COOLS GUY
BE 0477.007.495
Sint-Katelijne-Waver · Eq €696,011
FACE CLINIC
BE 0637.987.905
Waterloo · Eq €695,399
DOKTER KATTY BOURGOIGNIE
BE 0458.551.167
Oostende · Eq €695,301
NEURINTENSIVE
BE 0769.367.178
Wezembeek-Oppem · Eq €695,266
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,162 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-11-2005
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 19 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.